Section .0100 ‑ Sickle Cell Syndrome Program

Link to law: http://reports.oah.state.nc.us/ncac/title 10a - health and human services/chapter 43 - personal health/subchapter h/subchapter h rules.html
Published: 2015

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Subscribe Now
SUBCHAPTER 43H ‑ SICKLE CELL SYNDROME: GENETIC

COUNSELING:

CHILDREN AND YOUTH SECTION

 

SECTION .0100 ‑ SICKLE CELL SYNDROME PROGRAM

 

10A NCAC 43H .0101       RESERVED FOR FUTURE CODIFICATION

10A NCAC 43H .0102       EDUCATION

A program for voluntary testing shall begin no sooner than

60 days after the implementation of an adequate and effective education

program.

 

History Note:        Authority G.S. 130A‑129;

Eff. February 1, 1976;

Readopted Eff. December 5, 1977;

Amended Eff. September 1, 1990.

 

10A NCAC 43H .0103       TESTING

(a)  Testing services are made available to individuals

requesting these services, especially those in the childbearing age groups. 

The division shall provide, without cost, testing and counseling services in

conjunction with the local health departments.  Voluntary testing shall not be

done without adequate counseling and educational services.

(b)  Testing shall be encouraged by the sickle cell syndrome

program on a voluntary individual basis.

 

History Note:        Authority G.S. 130A‑129;

Eff. February 1, 1976;

Amended Eff. April 22, 1977;

Readopted Eff. December 5, 1977;

Amended Eff. September 1, 1990; July 1, 1982.

 

10A NCAC 43H .0104       RESERVED FOR FUTURE CODIFICATION

 

10A NCAC 43H .0105       LABORATORY SERVICES

The laboratory services of the state laboratory of public

health shall be available only to health departments and local physicians

unless otherwise approved by the program.

 

History Note:        Authority G.S. 130A‑129;

Eff. February 1, 1976;

Readopted Eff. December 5, 1977;

Amended Eff. September 1, 1990.

 

10A NCAC 43H .0106       FORMS FOR COLLECTING BLOOD

Forms used for the collection of blood specimens may be

obtained by writing the Sickle Cell Syndrome Program, Division of Public

Health, 1915 Mail Service Center, Raleigh, North Carolina 27699-1915.  All information

requested on the form shall be given.  Age of patient, blood transfusion

information, and other factors are considered when interpreting the test

results.  Final results cannot be reported unless the address of the sender is

indicated on each form.

 

History Note:        Authority G.S. 130A‑129;

Eff. February 1, 1976;

Readopted Eff. December 5, 1977;

Amended Eff. September 1, 1990.

 

10A NCAC 43H .0107       RESERVED FOR FUTURE CODIFICATION

 

10A NCAC 43H .0108       RESERVED FOR FUTURE CODIFICATION

 

10A NCAC 43H .0109       COUNSELING

Adequate follow‑up procedures and counseling

techniques shall be provided to patients who have positive test results.

 

History Note:        Authority G.S. 130A‑129;

Eff. February 1, 1976;

Readopted Eff. December 5, 1977;

Amended Eff. September 1, 1990.

 

10A NCAC 43H .0110       ELIGIBILITY REQUIREMENTS

(a)  Eligibility requirements for medical services shall be

based on income and diagnosis.  In order to be considered for medical services,

the individual must be diagnosed as having one of the following disorders:

(1)           sickle cell anemia,

(2)           sickle cell/hemoglobin D disease,

(3)           sickle cell/hemoglobin C disease,

(4)           sickle cell beta thalassemia, or

(5)           sickle cell hemoglobin that coexist with

other abnormal hemoglobins with symptomatic abnormal clinical manifestations.

(b)  Financial eligibility for sickle cell syndrome program

medical services shall be determined in accordance with rules found in 10A NCAC

45A.

 

History Note:        Authority G.S. 130A‑129;

Eff. February 1, 1976;

Amended Eff. April 22, 1977;

Readopted Eff. December 5, 1977;

Amended Eff. September 1, 1990; July 1, 1981.

 

10a ncac 43h .0111       MEDICAL SERVICES COVERED

The following medical services are covered under the N.C.

Sickle Cell Syndrome Program if the North Carolina Division of Public Health

Sickle Cell Program Supervisor determines that these services are related to

sickle cell disease:

(1)           hospital outpatient care including emergency room

visits.  The total number of emergency room visits per fiscal year shall not

exceed three times the average number of emergency visits per patient over the

previous two fiscal years, and it will be adjusted annually on July 1.

(2)           physicians' office visits;

(3)           drugs on a formulary established by the program

based upon the following factors: the medical needs of sickle cell patients,

the efficacy and cost effectiveness of the drugs, the availability of generic

or other less costly alternatives, and the need to maximize the benefits to

patients utilizing finite Program dollars.  A copy of this formulary may be

obtained free of charge by writing to the N.C. Sickle Cell Syndrome Program,

1929 Mail Service Center, Raleigh, North Carolina, 27699-1929 or on the

Purchase of Medical Care Services website at http://www.ncdhhs.gov/control/pomcs/guides/billing_sicklecell.pdf;

(4)           medical supplies and equipment;

(5)           preventive dentistry including education,

examinations, cleaning, and X-rays; remedial dentistry including tooth removal,

restoration, and endodontic treatment for pain prevention; and emergency dental

care to control bleeding, relieve pain, and treat infection; dental care,

including:

(a)           preventive dentistry including education,

examinations, cleaning, and X-rays;

(b)           remedial dentistry including tooth removal,

restoration, and endodontic treatment for pain prevention; and

(c)           emergency dental care to control bleeding,

relieve pain, and treat infection;

(6)           eye care (when the Division of Services for the

Blind will not provide coverage); and

(7)           the cost of inpatient care per client per year for

a maximum of two admissions per fiscal year.

 

History Note:        Authority G.S. 130A-129;

Eff. February 1, 1976;

Amended Eff. April 22, 1977;

Readopted Eff. December 5, 1977;

Amended Eff. July 1, 1982; January 1, 1982;

Temporary Amendment Eff. November 7, 1983, for a period of 120 days to expire on March 4, 1984;

Amended Eff. October 1, 1984; March 1, 1984;

Temporary Amendment Eff. October 14, 1988, for a period of 180 days to expire on April 12, 1989;

Temporary Amendment Expired April 12, 1989;

Amended Eff. September 1, 1990;

Temporary Amendment Eff. June 19, 1996;

Temporary Amendment Expired March 11, 1997;

Amended Eff. August 1, 2000;

Temporary Amendment Eff. December 17, 2001; December 1, 2001;

Amended Eff. April 1, 2003;

Temporary Amendment Eff. January 27, 2004;

Amended Eff. January 1, 2014; October 1, 2006; July 1,

2004.

 

10A NCAC 43H .0112       RESERVED FOR FUTURE CODIFICATION

 

10A NCAC 43H .0113       PROCEDURE FOR REQUESTING SERVICES

(a)  Any provider (physician, hospital, dentist) rendering

services to a patient with one of the named disorders may request reimbursement

services through the Sickle Cell Syndrome Program.  The request shall be made

by completing the appropriate program authorization request form.  The form

shall include:

(1)           biographical data of patient;

(2)           diagnoses (primary and secondary);

(3)           provider information including service

date(s);

(4)           request and describe service;

(5)           describe and justify treatment or service,

list other providers and state drug information if applicable;

(6)           check number services provided for

ambulatory visits and answer all questions pertaining to patient's treatment

and financial support; and

(7)           signature of physician or dentist, address

and date of request.

(b)  A financial eligibility form shall be submitted in

accordance with rules found in 10A NCAC 45A.

 

History Note:        Authority G.S.130A-129;

Eff. February 1, 1976;

Readopted Eff. December 5, 1977;

Amended Eff. July 1, 1982; April 1, 1982;

Temporary Amendment Eff. June 19, 1996;

Temporary Amendment Expired on March 11, 1997;

Amended Eff. August 1, 2000.

 

10A NCAC 43H .0114       RESERVED FOR FUTURE CODIFICATION

 

10A NCAC 43H .0115       REIMBURSEMENT

Reimbursement shall be made in accordance with rules found

in 10A NCAC 45A.

 

History Note:        Authority G.S. 143B‑193;

Eff. February 1, 1976;

Readopted Eff. December 5, 1977;

Amended Eff. April 1, 1982.

 

10A NCAC 43H .0116       CLAIMS FOR REIMBURSEMENT

Claims for payment shall be submitted in accordance with

rules found in 10A NCAC 45A.

 

History Note:        Authority G.S. 143B‑193;

Eff. February 1, 1976;

Readopted Eff. December 5, 1977;

Amended Eff. April 1, 1982.

 

10A NCAC 43H .0117       RESERVED FOR FUTURE CODIFICATION

 

10A NCAC 43H .0118       REIMBURSEMENT RATES

Reimbursement rates for the sickle cell syndrome program are

found in 10A NCAC 45A .0400.

 

History Note:        Filed as a Temporary Rule Eff. August 15,

1982, for a period of 120 days to expire on December 12, 1982;

Authority G.S. 143B‑193;

Eff. October 1, 1982.

 

SECTION .0200 ‑ SICKLE CELL CONTRACT FUNDS

 

10A NCAC 43H .0201       RESERVED FOR FUTURE CODIFICATION

 

10A NCAC 43H .0202       DEFINITIONS

The following definitions shall apply throughout this

Subchapter:

(1)           "Sickle cell disease" means sickle cell

anemia (Hgb.SS), sickle C disease (Hgb.SC), sickle D disease (Hgb.SD), sickle‑Thalassemia

(Hgb. S‑Thal), and includes sickle cell hemoglobin that co‑exists

with other abnormal hemoglobins with symptomatic abnormal clinical

manifestations.

(2)           "Education" means making the general

population aware of sickle cell syndrome (i.e., the difference between sickle

cell disease and the carrier status of abnormal hemoglobins.)  This term also

means educational sessions for provision of sickle cell information to the lay

public and medical and non‑medical professionals.

(3)           "Counseling" means a clear communication

of the diagnosis, psychological, social, and genetic factors relating to the

specific condition.  Counseling also includes information on risk,

reoccurrence, and prognosis, and alternatives for prevention and treatment of

the condition diagnosed.

(4)           "Counseling follow‑up" means that

the initial counseling session was not adequately completed and there is the

need to follow‑up with additional counseling session in order to provide

the necessary genetic information based on test results.

(5)           "Case management services" means the

facilitation and provision of medical, educational, and psychosocial services

provided through developing and monitoring individual service care plans.

 

History Note:        Authority G.S. 130A‑124;

Eff. April 1, 1985;

Amended Eff. September 1, 1990.

 

10A NCAC 43H .0203       PROVIDER ELIGIBILITY

(a)  Funds may be awarded to any public or private non‑profit

agency that can demonstrate the capacity to provide comprehensive sickle cell

services as described in Rule .0205 of this Subchapter.

(b)  All contract agency staff involved in provision of

comprehensive sickle cell services shall be qualified and adequately trained

within six months after being employed by the agency.

 

History Note:        Authority G.S. 130A‑124;

Eff. April 1, 1985;

Amended Eff. September 1, 1990.

 

10A NCAC 43H .0204       CLIENT ELIGIBILITY

Anyone who is a resident of North Carolina can receive

sickle cell services as otherwise provided in these Rules.  All services

provided by the contract agency shall be provided free of charge.

 

History Note:        Authority G.S. 130A‑124;

Eff. April 1, 1985;

Amended Eff. September 1, 1990.

 

10A NCAC 43H .0205       SCOPE OF SERVICES

(a)  Contract providers shall provide comprehensive sickle

cell services.  Comprehensive sickle cell services include education,

counseling, counseling follow‑up, medical reimbursement assistance, and

case management services.

(b)  Within the service limitations of this Section and

commensurate with funds available to pay for those services as specified in the

approved contract budget, the number and type of services offered will be

negotiated annually with each provider, approved by the program, and detailed

in the addendum of the contract.

 

History Note:        Authority G.S. 130A‑124;

Eff. April 1, 1985.

 

10A NCAC 43H .0206       ALLOCATION OF FUNDS

(a)  Each provider will receive an allocation based on the

previous year's allocation as long as service objectives are met and delivered

according to all other aspects of the rules of the Section.

(b)  New funds shall be distributed based on the following

considerations:

(1)           One‑half of the weight shall be given

to the incidence of sickle cell disease in the contractor's service area as a

percentage of the incidence of sickle cell disease in all contractors' service

areas.  The incidence of sickle cell disease in all contractors' service areas

shall be considered to be one per 294 of the non‑white population;

(2)           One‑quarter of the weight shall be

given to the total rural population in the contractor's service area as a

percentage of the rural population in all contractors' service areas.  Rural

population shall be that determined by the most recent official U.S. census;

(3)           One‑quarter of the weight shall be

given to the square miles in the contractor's service area as a percentage of

all square miles in all contractors' service areas.

(c)  In order to maximize the utilization of sickle cell

funds, in the event a provider is expending funds at a rate which will, if

continued, result in an underexpenditure of funds at the end of the contract

period, the Sickle Cell Syndrome Program may after consulting with the provider

reduce the amount of funds budgeted by an amount consistent with the projected

level of underexpenditure.  Funds projected to be unexpended may be reallocated

to other providers in accordance with community needs and performance records. 

The Sickle Cell Syndrome Program shall notify the contract provider in writing

prior to any reduction of funds.

(d)  A contract is signed annually with each provider.  Contracts

for sickle cell funds are subject to annual renewal and are subject to the

availability of funds.

(e)  A provider that consistently fails to meet acceptable

levels of performance as determined through site reviews by the program or data

from quarterly and annual reporting forms and has been offered state

consultation and technical assistance, may have sickle cell funding reduced or

discontinued.  Recommendations to reduce or discontinue funding to a service

provider must be reviewed and approved by the State Health Director.

 

History Note:        Authority G.S. 130A‑124;

Eff. April 1, 1985;

Amended Eff. December 1, 1987.

 

10A NCAC 43H .0207       REPORTING REQUIREMENTS

Contract providers shall submit monthly reports on the

Sickle Cell Program's monthly report form.  Additional reports may be required

by the program for special programmatic needs.

 

History Note:        Authority G.S. 130A‑124;

Eff. April 1, 1985.

 

10A NCAC 43H .0208       APPLICATION FOR FUNDS

(a)  Contracts for sickle cell funds shall be awarded

through a request for proposal (RFP) process that includes notification of all

contract providers of the eligibility criteria and requirements for funding.

(b)  Contract proposals for sickle cell funds shall be sent

to the Children and Youth Section.  The proposal shall include the following

information:

(1)           A service plan which includes an assessment

of needs, measurable objectives, and strategies for meeting the objectives.

(2)           A proposed budget.

(3)           An evaluation plan.

(c)  Technical assistance in preparing a contract proposal

shall be available from central and regional staff.

(d)  The Section shall approve or deny a proposal for funds

or request additional information within 60 days after receipt of a proposal. 

If additional information is requested, the local provider shall have 45 days

to submit the information.  Failure by the contract provider to submit the

additional information requested within 45 days shall be grounds for denying

the contract proposal.  Upon receipt of the additional information, the Section

shall approve or deny a contract proposal for funds within 45 days.

 

History Note:        Authority G.S. 130A‑124;

Eff. April 1, 1985;

Amended Eff. September 1, 1990.

 

10A NCAC 43H .0209       BUDGET OF CONTRACT FUNDS

Upon approval of an application for contract funds a budget

will be negotiated and a contract signed between the contractee and the

Children and Youth Section.

 

History Note:        Authority G.S. 130A‑124;

Eff. April 1, 1985.

 

10A NCAC 43H .0210       RENEWAL OF CONTRACT FUNDS

Contracts for sickle cell funds are subject to annual

renewal based upon the extent to which objectives are met as described in

progress reports or site reviews by the program and contract requirements are

met.

 

History Note:        Authority G.S. 130A‑124;

Eff. April 1, 1985.

 

SECTION .0300 ‑ GENETIC HEALTH CARE

 

10A NCAC 43H .0301       GENERAL

The Genetic Health Care Program is

administered by the Children and Youth Section.

 

History Note:        Authority G.S. 130A‑124;

Eff. April 1, 1985;

Amended Eff. September 1, 1990.

 

10A NCAC 43H .0302       RESERVED FOR FUTURE CODIFICATION

 

10A NCAC 43H .0303       DEFINITIONS

The following definitions shall apply

throughout this Section:

(1)           "Division" means the

Division of Public Health.

(2)           "Branch" means the

Specialized Services.

(3)           "GHC" means Genetic Health

Care.

(4)           "Program" refers to the

central office staff responsible for statewide management of the Genetic Health

Care network.

(5)           "Provider" means a public

or private nonprofit agency receiving Genetic Health Care Program funds.

 

History Note:        Authority G.S. 130A‑124;

Eff. April 1, 1985.

 

10A NCAC 43H .0304       PROVIDER ELIGIBILITY

(a)  Medical centers which provide pediatric,

obstetrical, and neonatal services are eligible to receive genetic funds. 

Consideration will be given to other qualified public or private non‑profit

agencies for special categorical services.

(b)  Providers must be able to demonstrate a

capability for providing genetic services as described in Rule .0306 of the

Subchapter.

(1)           Each provider must have an

M.D. clinical geneticist and a Master's level genetic counselor.  All clinical

and counseling staff must be board‑eligible or board‑certified by

the American Board of Medical Genetics.

(2)           Each provider must

demonstrate evidence of an association with a cytogenetics laboratory, the

director of which must be board‑eligible or board‑certified by the

American Board of Medical Genetics.

(c)  Current providers are eligible to receive

priority for program funds according to their compliance with rules and

performance expectations.

 

History Note:        Authority G.S. 130A‑124;

Eff. April 1, 1985;

Amended Eff. September 1, 1990.

 

10A NCAC 43H .0305       CLIENT ELIGIBILITY

Any North Carolina resident suspected of

having a genetic disorder can be referred for genetic services.  No family is

denied service because of inability to pay.  All families who meet the

financial eligibility of the Children's Special Health Services Program will

receive service free of charge.

 

History Note:        Authority G.S. 130A‑124;

Eff. April 1, 1985;

Amended Eff. September 1, 1990.

 

10A NCAC 43H .0306       SCOPE OF SERVICES

(a)  Providers may utilize the Genetic Health

Care Program funds to provide the following services and programs:

(1)           Complete diagnostic

evaluations, genetic counseling, and follow‑up.  Diagnostic evaluations

include medical history, medical examination, and all laboratory tests

performed during the work‑up.

(2)           Categorical screening

programs.

(3)           Community outreach including

education, satellite clinics, and follow‑up.

(b)  Providers may not utilize Genetic Health

Care funds for the following:

(1)           Salary support for personnel

other than those who provide secretarial or direct clinical genetic services.

(2)           Purchase of materials and

equipment unless used primarily in the delivery of genetic services.

(3)           Provision of basic clinical

research.

(c)  Within the service limitations of this

Section and commensurate with funds available to pay for those services as

specified in the approved contract budget, the number and type of services

offered will be negotiated annually with each provider, approved by the

program, and detailed in the addendum of the contract.

 

History Note:        Authority G.S. 130A‑124;

Eff. April 1, 1985.

 

10A NCAC 43H .0307       ALLOCATION OF FUNDS

(a)  Each provider will receive continuing allocations based

on the previous fiscal year as long as services are provided according to

program rules and service expectations are met, subject to the availability of funds.(b) 

New monies will be distributed based on a statewide plan developed by the

program in accordance with the following:

(1)           Population at risk;

(2)           Service delivery gaps in given localities;

(3)           Actual utilization of funds in previous

fiscal years, special population groups, and other management considerations

that relate to a provider's ability to effectively and efficiently use

additional funds.

(c)  In order to maximize the utilization of genetic health

care funds, in the event a provider is expending funds at a rate which will, if

continued, result in an underexpenditure of funds at the end of the contract

period, the Genetic Health Care Unit may after consulting with the provider

reduce the amount of funds budgeted by an amount consistent with the projected

level of underexpenditure.  Funds projected to be unexpended may be reallocated

to other providers in accordance with community needs and performance records. 

The Genetic Health Care Unit shall notify the contract provider in writing

prior to any reduction of funds.

(d)  A contract is signed annually with each provider. 

Contracts for genetic health care funds are subject to annual renewal and are

subject to the availability of funds.

(e)  A provider that consistently fails to meet acceptable levels

of performance as determined through site reviews by the program or data from

quarterly and annual reporting forms and has been offered state consultation

and technical assistance, may have genetic health care funding reduced or

discontinued.  Recommendations to reduce or discontinue funding to a service

provider must be reviewed and approved by the State Health Director.

 

History Note:        Authority G.S. 130A‑124;

Eff. April 1, 1985.

 

10A NCAC 43H .0308       REPORTING REQUIREMENTS

Providers receiving genetic funds must report

client and service data as required by the Children and Youth Section.  These

reports are to be submitted on a quarterly basis.  An annual report shall be

submitted within 45 days after the end of the contract period summarizing

client and service data, major program achievements and problem areas

accompanied with problem‑solving strategies.

 

History Note:        Authority G.S. 130A‑124;

Eff. April 1, 1985;

Amended Eff. September 1, 1990.

 

10A NCAC 43H .0309       CLIENT AND THIRD PARTY FEES

(a)  Providers are required to bill all

available and appropriate reimbursement sources including at least insurance

companies, Medicaid, other agency providers and parents/guardians.  The

Children's Special Health Services Program may not be billed.

(b)  Fees will be based on a public schedule

of charges approved by the Division of Public Health.  Families that are

financially eligible for the Children's Special Health Services Program may not

be billed.

(c)  All fees collected must be budgeted and

expended during the fiscal year earned or within the subsequent fiscal year. 

Fees will be utilized, upon approval of the program, to either expand program

services or to reduce the amount of state appropriations.

(d)  All fees brought forward from the prior fiscal year

shall be expended prior to the expenditure of state appropriations.

 

History Note:        Authority G.S. 130A‑124;

Eff. April 1, 1985;

Amended Eff. September 1, 1990.

 

10A NCAC 43H .0310       APPLICATION FOR FUNDS

(a)  Grants for special genetic health care

projects shall be awarded through a request for proposal (RFP) process that

includes notification of all contract providers of the eligibility criteria and

requirements for funding.

(b)  Grant proposals for genetic health care

funds shall be sent to the Children and Youth Section.  The grant proposal

shall include the following information:

(1)           A project plan which

includes an assessment of the need for the special project, measurable project

objectives, and strategies for meeting the project objectives.

(2)           A proposed budget.

(3)           An evaluation plan.

(c)  Technical assistance in preparing a grant

proposal shall be available from central and regional genetic health care staff.

(d)  The Children and Youth Section shall

approve or deny a grant proposal for special project funds or request

additional information within 60 days after receipt of a grant proposal.  If

additional information is requested, the local provider shall have 45 days to

submit the information.  Failure by the contract provider to submit the

additional information requested within 45 days shall be grounds for denying

the grant proposal.  Upon receipt of the additional information, the Children

and Youth Section shall approve or deny a grant proposal for special project

funds within 45 days.

 

History Note:        Authority G.S. 130A‑124;

Eff. April 1, 1985;

Amended Eff. September 1, 1990.

 

10A NCAC 43H .0311       BUDGETING OF GRANT FUNDS

Upon approval of an application for grant

funds a budget will be negotiated and a contract signed between the grantee and

the Children and Youth Section.

 

History Note:        Authority G.S. 130A‑124;

Eff. April 1, 1985.

 

10A NCAC 43H .0312       ANNUAL REPORT

Providers shall submit an annual report to the

Children and Youth Section within 45 days from the close of the contract

period.  The report shall include an evaluation addressing progress in meeting

the objectives outlined in the application.

 

History Note:        Authority G.S. 130A‑124;

Eff. April 1, 1985;

Amended Eff. September 1, 1990.

 

10A NCAC 43H .0313       RENEWAL OF GRANT FUNDS

Contracts for Genetic Health Care funds are

subject to annual renewal based upon the extent to which objectives are met as

described in progress reports or site reviews by the program and contract

requirements are met.

 

History Note:        Authority G.S. 130A‑124;

Eff. April 1, 1985.

 

10A NCAC 43H .0314       SUBMISSION OF BLOOD SPECIMENS FOR

SCREENING OF NEWBORNS

(a)  The attending physician shall draw a blood specimen for

each infant born in North Carolina and shall submit such specimens to the North

Carolina State Laboratory for Public Health for testing for the following

metabolic and other hereditary and congenital disorders:

(1)           phenylketonuria (PKU);

(2)           galactosemia;

(3)           congenital primary hypothyroidism;

(4)           congenital adrenal hyperplasia

(21-hydroxylase deficiency); and

(5)           sickle cell disease.

(b)  Notwithstanding Paragraph (a) of this Rule, parents or

guardians may object to screening in accordance with G.S. 130A‑125(b).

(c)  The hearing screening component of the Department's

Newborn Screening Program is found in 10A NCAC 43F .1200.

 

History Note:        Authority G.S. 130A‑125;

Eff. April 1, 1992;

Transferred and Recodified from 15A NCAC 21E .0501 Eff. February 10, 1993;

Amended Eff. April 1, 1994;

Temporary Amendment Eff. October 1, 1999;

Amended Eff. August 1, 2000.